XML 36 R25.htm IDEA: XBRL DOCUMENT v3.22.0.1
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2021
Summary Of Significant Accounting Policies [Line Items]  
Summary of Estimated Useful Lives of Property and Equipment

A summary of estimated useful lives is as follows:

 

Leasehold Improvements

15 to 39 Years

Furniture and Equipment

5 to 7 Years

Vehicles

5 Years

Software

3 Years

Summary of Financial Statement Adjustments Related to Restatement

The table below presents the effect of the financial statement adjustments related to the restatement of the Company's unaudited condensed consolidated balance sheet as of June 30, 2021 reported in the Original Filing:

 

 

June 30, 2021

 

 

As Previously Reported

 

Adjustments

 

As Restated

 

ASSETS

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT ASSETS

 

 

 

 

 

 

Cash

$

170,080

 

$

-

 

$

170,080

 

Restricted cash

 

1,956

 

 

-

 

 

1,956

 

Accounts receivable, net

 

32,031

 

 

-

 

 

32,031

 

Inventory

 

190

 

 

-

 

 

190

 

Prepaid expenses

 

3,449

 

 

-

 

 

3,449

 

Risk settlements due from providers

 

288

 

 

-

 

 

288

 

Due from related parties

 

-

 

 

-

 

 

-

 

Total Current Assets

 

207,994

 

 

-

 

 

207,994

 

 

 

 

 

 

 

 

Property and equipment, net

 

12,728

 

 

-

 

 

12,728

 

Goodwill

 

356,360

 

 

2,438

 

 

358,798

 

Intangible assets, net

 

50,357

 

 

-

 

 

50,357

 

Deferred debt issuance costs

 

2,195

 

 

-

 

 

2,195

 

Other assets

 

998

 

 

-

 

 

998

 

Total Assets

$

630,632

 

$

2,438

 

$

633,070

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS'/MEMBERS' EQUITY

 

 

 

 

 

 

 

 

 

 

 

 

 

 

CURRENT LIABILITIES

 

 

 

 

 

 

Accounts payable

$

2,546

 

$

-

 

$

2,546

 

Accrued expenses

 

10,689

 

 

-

 

 

10,689

 

Accrued interest payable

 

264

 

 

-

 

 

264

 

Risk settlements due to providers

 

178

 

 

-

 

 

178

 

Current portion of long-term debt

 

6,672

 

 

-

 

 

6,672

 

Due to related parties

 

-

 

 

-

 

 

-

 

Current portion of contingent earnout liabilities

 

-

 

 

36,286

 

 

36,286

 

Other current liabilities

 

5,771

 

 

-

 

 

5,771

 

Total Current Liabilities

 

26,120

 

 

36,286

 

 

62,406

 

 

 

 

 

 

 

 

Derivative warrant liabilities

 

27,337

 

 

-

 

 

27,337

 

Long-term debt, less current portion

 

114,222

 

 

-

 

 

114,222

 

Contingent earnout liabilities

 

-

 

 

36,286

 

 

36,286

 

Other liabilities

 

2,639

 

 

-

 

 

2,639

 

Total Liabilities

 

170,318

 

 

72,571

 

 

242,889

 

COMMITMENTS AND CONTINGENCIES

 

 

 

 

 

 

STOCKHOLDERS'/MEMBER'S EQUITY

 

 

 

 

 

 

Class A common stock ($0.0001 par value; 250,000,000 shares
 authorized;
80,632,457 shares issued and outstanding at June 30, 2021)

 

8

 

 

-

 

 

8

 

Additional paid-in-capital

 

459,641

 

 

(87,553

)

 

372,088

 

Retained Earnings

 

665

 

 

17,420

 

 

18,085

 

Member units (no par value, 200 authorized, issued and outstanding at
 December 31, 2020)

 

-

 

 

-

 

 

-

 

Members' equity

 

-

 

 

-

 

 

-

 

 

 

 

 

 

 

 

Total Stockholders'/Members' Equity

 

460,314

 

 

(70,133

)

 

390,181

 

 

 

 

 

 

 

 

Total Liabilities and Stockholders'/Members' Equity

$

630,632

 

$

2,438

 

$

633,070

 

 

The tables below present the effect of the financial statement adjustments related to the restatement of the unaudited condensed consolidated statements of operations for the three and six-months ended June 30, 2021 reported in the Original Filing:

 

 

Three Months Ended June 30, 2021

 

 

As Previously Reported

 

Adjustments

 

As Restated

 

Revenue

 

 

 

 

 

 

Medicare risk-based revenue

$

37,761

 

$

-

 

$

37,761

 

Medicaid risk-based revenue

 

5,449

 

 

-

 

 

5,449

 

Other revenue

 

1,709

 

 

-

 

 

1,709

 

Total revenue

 

44,919

 

 

-

 

 

44,919

 

 

 

 

 

 

 

 

Operating expenses

 

 

 

 

 

 

External provider costs

 

35,535

 

 

-

 

 

35,535

 

Cost of care

 

7,867

 

 

-

 

 

7,867

 

Sales and marketing

 

775

 

 

-

 

 

775

 

Corporate, general and administrative

 

8,881

 

 

-

 

 

8,881

 

Depreciation and amortization

 

1,437

 

 

-

 

 

1,437

 

Acquisition related costs

 

149

 

 

-

 

 

149

 

Total operating expenses

 

54,644

 

 

-

 

 

54,643

 

Operating (loss)

 

(9,725

)

 

-

 

 

(9,724

)

Interest expense, net

 

(792

)

 

-

 

 

(792

)

Gain on remeasurement of warrant liabilities

 

1,795

 

 

-

 

 

1,795

 

Gain on remeasurement of contingent earnout liabilities

 

-

 

 

17,420

 

 

17,420

 

Gain on extinguishment of debt

 

1,358

 

 

-

 

 

1,358

 

(Loss) income before income tax

 

(7,364

)

 

17,420

 

 

10,057

 

Income tax provision

 

-

 

 

-

 

 

-

 

Net (loss) income

$

(7,364

)

$

17,420

 

$

10,057

 

 

 

 

 

 

 

 

Net (loss) income attributable to non-controlling interest

 

-

 

 

-

 

 

-

 

Net (loss) income attributable to controlling interest

$

(7,364

)

$

17,420

 

$

10,057

 

 

 

 

 

 

 

 

Net (loss) income attributable to CareMax, Inc. Class A common stockholders

$

(7,364

)

$

17,420

 

$

10,057

 

Weighted average basic shares outstanding

 

28,404,759

 

 

-

 

 

28,404,759

 

Weighted average diluted shares outstanding

 

28,404,759

 

 

2,502,100

 

 

30,906,859

 

Net (loss) income per share

 

 

 

 

$

-

 

Basic

$

(0.26

)

$

0.61

 

$

0.35

 

Diluted

$

(0.26

)

$

0.58

 

$

0.33

 

 

 

Six Months Ended June 30, 2021

 

 

As Previously Reported

 

Adjustments

 

As Restated

 

Revenue

 

 

 

 

 

 

Medicare risk-based revenue

$

65,577

 

$

-

 

$

65,577

 

Medicaid risk-based revenue

 

5,449

 

 

-

 

 

5,449

 

Other revenue

 

1,811

 

 

-

 

 

1,811

 

Total revenue

 

72,837

 

 

-

 

 

72,837

 

 

 

 

 

 

 

-

 

Operating expenses

 

 

 

 

 

-

 

External provider costs

 

53,694

 

 

-

 

 

53,694

 

Cost of care

 

13,220

 

 

-

 

 

13,220

 

Sales and marketing

 

1,066

 

 

-

 

 

1,066

 

Corporate, general and administrative

 

10,676

 

 

-

 

 

10,676

 

Depreciation and amortization

 

1,951

 

 

-

 

 

1,951

 

Acquisition related costs

 

149

 

 

-

 

 

149

 

Total operating expenses

 

80,756

 

 

-

 

 

80,755

 

Operating (loss)

 

(7,919

)

 

-

 

 

(7,918

)

Interest expense, net

 

(1,296

)

 

-

 

 

(1,296

)

Gain on remeasurement of warrant liabilities

 

1,795

 

 

-

 

 

1,795

 

Gain on remeasurement of contingent earnout liabilities

 

-

 

 

17,420

 

 

17,419.73

 

Gain on extinguishment of debt

 

1,358

 

 

-

 

 

1,358

 

(Loss) income before income tax

 

(6,062

)

 

17,420

 

 

11,359

 

Income tax provision

 

-

 

 

-

 

 

-

 

Net (loss) income

$

(6,062

)

$

17,420

 

$

11,359

 

 

 

 

 

 

$

-

 

Net (loss) income attributable to non-controlling interest

 

-

 

 

-

 

 

-

 

Net (loss) income attributable to controlling interest

$

(6,062

)

$

17,420

 

$

11,359

 

 

 

 

 

 

$

-

 

Net (loss) income attributable to CareMax, Inc. Class A common stockholders

$

(6,062

)

$

17,420

 

$

11,359

 

Weighted average basic shares outstanding

 

19,649,057

 

 

-

 

 

19,649,057

 

Weighted average diluted shares outstanding

 

19,649,057

 

 

1,257,962

 

 

20,907,019

 

Net (loss) income per share

 

 

 

 

 

 

Basic

$

(0.31

)

$

0.89

 

$

0.58

 

Diluted

$

(0.31

)

$

0.85

 

$

0.54

 

 

The table below presents the effect of the financial statement adjustments related to the restatement of the reported earnings per share as of June 30, 2021 reported in the Original Filing:

 

 

 

Three Months Ended June 30,

 

 

 

As Reported

 

Adjustments

 

As Restated

 

Net (loss) income attributable to CareMax, Inc. Class A common stockholders

 

$

(7,364

)

$

17,420

 

$

10,057

 

 

 

 

 

 

 

 

 

Weighted average basic shares outstanding

 

 

28,404,759

 

 

-

 

 

28,404,759

 

Dilutive impact of contingently issuable equity

 

 

-

 

 

2,502,100

 

 

2,502,100

 

Weighted average diluted shares outstanding

 

 

28,404,759

 

 

2,502,100

 

 

30,906,859

 

 

 

 

 

 

 

 

 

Net (loss) template per share

 

 

 

 

 

 

 

Basic

 

$

(0.26

)

$

0.61

 

$

0.35

 

Diluted

 

$

(0.26

)

$

0.59

 

$

0.33

 

 

 

Six Months Ended June 30,

 

 

As Reported

 

Adjustments

 

As Restated

 

Net (loss) income attributable to CareMax, Inc. Class A common stockholders

$

(6,062

)

$

17,420

 

$

11,359

 

 

 

 

 

 

 

 

Weighted average basic shares outstanding

 

19,649,057

 

 

-

 

 

19,649,057

 

Dilutive impact of contingently issuable equity

 

-

 

 

1,257,962

 

 

1,257,962

 

Weighted average diluted shares outstanding

 

19,649,057

 

 

1,257,962

 

 

20,907,019

 

 

 

 

 

 

 

 

Net (loss) template per share

 

 

 

 

 

 

Basic

$

(0.31

)

$

0.89

 

$

0.58

 

Diluted

$

(0.31

)

$

0.85

 

$

0.54

 

 

The tables below present the effect of the financial statement adjustments related to the restatement of the condensed consolidated statements of changes in stockholders'/members' equity reported in the Original Filing:

 

 

As Reported

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Class A Common Stock

 

 

Additional

 

 

Total

 

 

Retained

 

 

Noncontrolling

 

 

Total

 

 

Shares

 

 

Amount

 

 

Paid-in-capital

 

 

Controlling Interest

 

 

Earnings

 

 

Interest

 

 

Equity

 

BALANCE - DECEMBER 31, 2020

 

-

 

 

$

-

 

 

$

-

 

 

$

6,727

 

 

$

-

 

 

$

-

 

 

$

6,727

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

1,302

 

 

 

-

 

 

 

-

 

 

 

1,302

 

Distributions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BALANCE- MARCH 31, 2021

 

-

 

 

 

-

 

 

 

-

 

 

 

8,029

 

 

 

-

 

 

 

-

 

 

 

8,029

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Activity prior to the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(6,487

)

 

 

-

 

 

 

-

 

 

 

(6,487

)

Effects of the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reverse recapitalization

 

28,780,819

 

 

 

3

 

 

 

(137,426

)

 

 

(1,542

)

 

 

1,542

 

 

 

-

 

 

 

(137,423

)

Equity consideration issued to acquire IMC

 

10,412,023

 

 

 

1

 

 

 

155,346

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

155,347

 

Contingent earnout consideration

 

-

 

 

 

-

 

 

 

38,348

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

38,348

 

Shares issued for holdback

 

55,000

 

 

 

-

 

 

 

821

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

821

 

Proceeds from the sale of Class A common stock, net of offering costs

 

41,000,000

 

 

 

4

 

 

 

397,525

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

397,529

 

Activity after the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(877

)

 

 

-

 

 

 

(877

)

Equity consideration issued to acquire SMA

 

384,615

 

 

 

-

 

 

 

5,027

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,027

 

BALANCE- JUNE 30, 2021

 

80,632,457

 

 

$

8

 

 

$

459,641

 

 

$

-

 

 

$

665

 

 

$

-

 

 

$

460,314

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Adjustments

 

 

Class A Common Stock

 

 

Additional

 

 

Total

 

 

Retained

 

 

Noncontrolling

 

 

Total

 

 

Shares

 

 

Amount

 

 

Paid-in-capital

 

 

Controlling Interest

 

 

Earnings

 

 

Interest

 

 

Equity

 

BALANCE - DECEMBER 31, 2020

 

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

 

$

-

 

Net income (loss)

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Distributions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BALANCE- MARCH 31, 2021

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Activity prior to the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Effects of the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reverse recapitalization

 

-

 

 

 

-

 

 

 

(49,206

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(49,206

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Equity consideration issued to acquire IMC

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Contingent earnout consideration

 

-

 

 

 

-

 

 

 

(38,348

)

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(38,348

)

Shares issued for holdback

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Proceeds from the sale of Class A common stock, net of offering costs

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Activity after the business combination:

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

17,420

 

 

 

-

 

 

 

17,420

 

Equity consideration issued to acquire SMA

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BALANCE- JUNE 30, 2021

 

-

 

 

$

-

 

 

$

(87,553

)

 

$

-

 

 

$

17,420

 

 

$

-

 

 

$

(70,133

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

As restated

 

 

Class A Common Stock

 

 

Additional

 

 

Total

 

 

Retained

 

 

Noncontrolling

 

 

Total

 

 

Shares

 

 

Amount

 

 

Paid-in-capital

 

 

Controlling Interest

 

 

Earnings

 

 

Interest

 

 

Equity

 

BALANCE - DECEMBER 31, 2020

 

-

 

 

$

-

 

 

$

-

 

 

$

6,727

 

 

$

-

 

 

$

-

 

 

$

6,727

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

1,302

 

 

 

-

 

 

 

-

 

 

 

1,302

 

Distributions

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

BALANCE- MARCH 31, 2021

 

-

 

 

 

-

 

 

 

-

 

 

 

8,029

 

 

 

-

 

 

 

-

 

 

 

8,029

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Activity prior to the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net loss

 

-

 

 

 

-

 

 

 

-

 

 

 

(6,487

)

 

 

-

 

 

 

-

 

 

 

(6,487

)

Effects of the business combination:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Reverse recapitalization

 

28,780,819

 

 

 

3

 

 

 

(186,632

)

 

 

(1,542

)

 

 

1,542

 

 

 

-

 

 

 

(186,629

)

Equity consideration issued to acquire IMC

 

10,412,023

 

 

 

1

 

 

 

155,346

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

155,347

 

Contingent earnout consideration

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Shares issued for holdback

 

55,000

 

 

 

-

 

 

 

821

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

821

 

Proceeds from the sale of Class A common stock, net of offering costs

 

41,000,000

 

 

 

4

 

 

 

397,525

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

397,529

 

Activity after the business combination:

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net income

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

16,543

 

 

 

-

 

 

 

16,543

 

Equity consideration issued to acquire SMA

 

384,615

 

 

 

-

 

 

 

5,027

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

5,027

 

BALANCE- JUNE 30, 2021

 

80,632,457

 

 

$

8

 

 

$

372,088

 

 

$

-

 

 

$

18,085

 

 

$

-

 

 

$

390,181

 

 

The table below presents the effect of the financial statement adjustments related to the restatement of the condensed consolidated statement of cash flows for the six months ended June 30, 2021 reported in the Original Filing:

 

 

Six Months Ended June 30, 2021

 

 

As Previously Reported

 

Adjustments

 

As Restated

 

CASH FLOWS FROM OPERATING ACTIVITIES

 

 

 

 

 

 

Net (loss)/income

$

(6,062

)

$

17,420

 

$

11,359

 

Adjustments to reconcile net (loss)/income to net cash

 

 

 

 

 

 

(Used in)/provided by operating activities:

 

 

 

 

 

 

Depreciation expense

 

640

 

 

-

 

 

640

 

Amortization expense

 

1,321

 

 

-

 

 

1,321

 

Amortization of discount on debt and related issuance costs

 

135

 

 

-

 

 

135

 

Change in fair value of warrant liabilities

 

(1,795

)

 

-

 

 

(1,795

)

Change in fair value of contingent earnout liabilities

 

-

 

 

(17,420

)

 

(17,420

)

Gain on extinguishment of debt

 

(1,358

)

 

-

 

 

(1,358

)

Changes in operating assets and liabilities:

 

-

 

 

-

 

 

-

 

Accounts receivable

 

1,267

 

 

-

 

 

1,267

 

Prepaid expenses

 

(1,322

)

 

-

 

 

(1,322

)

Risk settlements due from/due to providers

 

(208

)

 

-

 

 

(208

)

Due from related parties

 

235

 

 

-

 

 

235

 

Other assets

 

(275

)

 

-

 

 

(275

)

Accounts payable

 

(2,113

)

 

-

 

 

(2,113

)

Accrued expenses

 

6,453

 

 

-

 

 

6,453

 

Other liabilities

 

(16

)

 

-

 

 

(16

)

Accrued interest

 

115

 

 

-

 

 

115

 

Net cash (used in)/provided by operating activities

 

(2,983

)

 

-

 

 

(2,983

)

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

 

 

 

 

Purchase of property and equipment

 

(1,527

)

 

-

 

 

(1,527

)

Acquisition of businesses

 

(210,252

)

 

-

 

 

(210,252

)

Purchase of noncontrolling interest ownership

 

-

 

 

-

 

 

-

 

Net cash used in investing activities

 

(211,779

)

 

-

 

 

(211,779

)

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

 

 

 

 

Proceeds from issuance of Class A common stock

 

410,000

 

 

-

 

 

410,000

 

Issuance costs of Class A common stock

 

(12,471

)

 

-

 

 

(12,471

)

Recapitalization transaction

 

(108,799

)

 

-

 

 

(108,799

)

Proceeds from borrowings on long-term debt and credit facilities

 

125,000

 

 

-

 

 

125,000

 

Principal payments on long-term debt

 

(24,496

)

 

-

 

 

(24,496

)

Payment of deferred financing costs

 

(6,883

)

 

-

 

 

(6,883

)

Long-term debt extinguishment costs

 

(487

)

 

-

 

 

(487

)

Borrowing under paycheck protection program

 

-

 

 

-

 

 

-

 

Distributions to members

 

-

 

 

-

 

 

-

 

Net cash provided by financing activities

 

381,864

 

 

-

 

 

381,864

 

 

 

 

 

 

 

 

NET INCREASE IN CASH

 

167,102

 

 

-

 

 

167,102

 

Cash - beginning of period

 

4,934

 

 

-

 

 

4,934

 

CASH - END OF PERIOD

$

172,036

 

$

-

 

$

172,036

 

The table below presents the effect of the financial statement adjustments in Note 3, Acquisitions, to the condensed financial statements reported in the Original Filings:

 

As Reported

 

Adjustments

 

As Restated

 

Cash consideration (1)

$

172,302

 

$

-

 

$

172,302

 

Share consideration (2)

$

155,347

 

$

-

 

$

155,347

 

Contingent consideration (3)

$

38,348

 

$

2,438

 

$

40,785

 

Other consideration (4)

$

1,271

 

 

 

$

1,271

 

 

The tables below presents the effect of the financial statement adjustments in Note 11, Fair Value Measurements to the condensed consolidated financial statements reported in the Original Filing:

 

As Reported

 

June 30, 2021

Quoted Prices
in Active
Markets

 

 

Significant other
Observable
Units

 

 

Significant other
Unobservable
Units

 

Description

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Derivative warrant liabilities

$

-

 

 

$

-

 

 

$

27,337

 

Liability-classified contingent consideration

$

-

 

 

$

-

 

 

$

1,499

 

 

 

 

 

 

 

 

 

 

 

Adjustment to include June 30, 2021 fair value of contingent consideration

 

June 30, 2021

Quoted Prices
in Active
Markets

 

 

Significant other
Observable
Units

 

 

Significant other
Unobservable
Units

 

Description

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Derivative warrant liabilities

$

-

 

 

$

-

 

 

$

-

 

Liability-classified contingent consideration

$

-

 

 

$

-

 

 

$

72,571

 

 

 

 

 

 

 

 

 

 

 

As Restated

 

June 30, 2021

Quoted Prices
in Active
Markets

 

 

Significant other
Observable
Units

 

 

Significant other
Unobservable
Units

 

Description

(Level 1)

 

 

(Level 2)

 

 

(Level 3)

 

Derivative warrant liabilities

$

-

 

 

$

-

 

 

$

27,337

 

Liability-classified contingent consideration

$

-

 

 

$

-

 

 

$

74,070